PULSE BIOSCIENCES, INC. — Director's Dealing 2022

Oct 12, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulse Biosciences, Inc. (PLSE)
CIK: 0001625101
Period of Report: 2022-10-07

Reporting Person: Levinson Mitchell E. (Director, Chief Strategy Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-10-07	Common Stock	P	8770	$2.29	Acquired	46274	Direct
2022-10-07	Common Stock	P	8810	$2.27	Acquired	12945	Indirect
2022-10-07	Common Stock	P	4400	$2.26	Acquired	5134	Indirect
2022-10-07	Common Stock	P	4500	$2.23	Acquired	5234	Indirect
2022-10-07	Common Stock	P	4300	$2.29	Acquired	5034	Indirect